2m 2m 2m 2m 2m 2m 2m
Green Thumb SV (GTBIF)
OTC
$8.02-$0.21 (-2.55%)
Price as of Jun 02, 2026- $1.6BMarket Cap
- 52.95%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Green Thumb SV (GTBIF)
$8.02-$0.21 (-2.55%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.2B +3.36% | 1.1B +7.83% | 1.1B +3.65% | 1.0B +13.86% | |
Cost of Revenue | 600.4M +12.01% | 536.0M +1.51% | 528.1M +2.85% | 513.4M +27.83% | |
Gross Profit | 574.9M -4.36% | 601.1M +14.17% | 526.5M +4.47% | 504.0M +2.45% | |
Sales and Marketing Expense | 437.2M +16.06% | 376.7M +10.19% | 341.9M +16.12% | 294.4M +6.25% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 145.4M +28.48% | 113.2M +12.32% | 100.8M +4.27% | 96.7M +41.20% | |
Total Operating Expenses | 437.2M +16.06% | 376.7M +10.19% | 341.9M -10.72% | 382.9M +38.19% | |
Operating Profit | 137.7M -38.64% | 224.4M +21.55% | 184.6M +52.51% | 121.1M -43.65% | |
Interest Income | 11.4M +25.38% | 9.1M +35.49% | 6.7M +64.55% | 4.1M +184.22% | |
Interest Expense | N/A N/A | N/A N/A | -19.1M -10.04% | -21.2M -3.53% | |
Interest Income and Expense and Net | 11.4M +25.38% | 9.1M +173.32% | -12.4M -27.76% | -17.1M -16.61% | |
Total Nonoperating Income and Expense | 125.7M +617.40% | -24.3M -15.03% | -28.6M +126.27% | -12.6M +28.02% | |
Income before Taxes | 263.4M +31.59% | 200.1M +28.25% | 156.0M +43.91% | 108.4M -47.10% | |
Income Taxes | 147.3M +16.64% | 126.3M +6.46% | 118.6M +25.17% | 94.8M -23.94% | |
Extraordinary Items | 0 -100.00% | 450,000 -91.77% | 5.5M +285.27% | 1.4M -70.09% | |
Net Income | 114.2M +56.20% | 73.1M +101.51% | 36.3M +202.78% | 12.0M -84.12% | |
Net Income from Continuing Operations Applicable to Common | 263.4M +31.59% | 200.1M +28.25% | 156.0M +43.91% | 108.4M -47.10% | |
Basic EPS and Net Income | 0.49 +58.06% | 0.31 +106.67% | 0.15 +200.00% | 0.05 -85.29% | |
Diluted EPS and Net Income | 0.48 +60.00% | 0.30 +100.00% | 0.15 +200.00% | 0.05 -84.85% | |
Basic Weighted Average Shares | 233.9M -1.25% | 236.8M -0.46% | 237.9M +0.51% | 236.7M +6.06% | |
Diluted Weighted Average Shares | 236.9M -2.09% | 241.9M +0.88% | 239.8M +0.73% | 238.1M +4.99% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 274.3M +59.77% | 171.7M +6.22% | 161.6M -9.03% | 177.7M -22.89% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 274.3M +59.77% | 171.7M +6.22% | 161.6M -9.03% | 177.7M -22.89% | |
Total Current Assets | 577.2M +42.90% | 403.9M +17.84% | 342.8M -2.44% | 351.4M -3.54% | |
Accumulated Depreciation | 278.2M +48.48% | 187.4M +47.19% | 127.3M +57.73% | 80.7M +78.55% | |
Property and Plant and Equipment and Net | 690.9M -3.51% | 716.0M +4.21% | 687.1M +23.17% | 557.9M +36.37% | |
Total Long-Term Assets | 690.9M -3.51% | 716.0M +4.21% | 687.1M +23.17% | 557.9M +36.37% | |
Total Assets | 2.8B +9.97% | 2.5B +1.89% | 2.5B +2.32% | 2.4B +2.00% | |
Income Taxes Payable | 0 -100.00% | 2.3M -78.22% | 10.7M +145.64% | 4.4M +185.40% | |
Total Short-Term Debt | 18.5M +53.33% | 12.1M +302.60% | 3.0M +188.91% | 1.0M +32.44% | |
Total Current Liabilities | 177.3M +7.48% | 165.0M +30.88% | 126.0M -14.00% | 146.6M -28.28% | |
Total Long-Term Debt | 226.4M -6.79% | 242.9M -20.50% | 305.5M +11.25% | 274.6M +14.84% | |
Total Long-Term Liabilities | 481.5M -4.53% | 504.3M -9.13% | 555.0M +5.93% | 523.9M +24.24% | |
Total Liabilities | 879.4M +17.58% | 747.9M -4.94% | 786.8M +2.44% | 768.1M +0.22% | |
Retained Earnings | 165.4M +222.67% | 51.3M +334.97% | -21.8M -62.44% | -58.1M -17.10% | |
Total Stockholders Equity | 1.9B +6.49% | 1.8B +5.07% | 1.7B +2.28% | 1.7B +2.70% | |
Total Shares Outstanding | 206.6M -51.15% | 423.0M +0.63% | 420.3M +1.37% | 414.6M +2.50% | |
Cash Flow | |||||
Cash from Operating Activities | 294.9M +51.10% | 195.2M -13.24% | 225.0M +41.88% | 158.6M +20.08% | |
Capital Expenditures | 81.1M +1.10% | 80.2M -63.56% | 220.0M +22.58% | 179.5M -4.45% | |
Cash from Investing Activities | -130.4M +45.63% | -89.5M -60.71% | -227.9M +3.62% | -219.9M -21.65% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -50.9M -46.71% | -95.6M +629.28% | -13.1M -251.64% | 8.6M -97.07% | |
Financials Ratio | |||||
Gross Margin | 48.91% -7.47% | 52.86% +5.88% | 49.93% +0.79% | 49.54% -10.02% | |
Operating Margin | 11.72% -40.64% | 19.74% +12.72% | 17.51% +47.13% | 11.90% -50.51% | |
Return on Assets | 4.29% +47.40% | 2.91% +97.37% | 1.47% +196.36% | 0.50% -87.66% | |
Return on Equity | 6.18% +47.63% | 4.19% +94.34% | 2.15% +195.45% | 0.73% -87.77% | |
Revenue Growth | 3.36% -57.16% | 7.83% +114.31% | 3.65% -73.63% | 13.86% -77.11% | |
Current Ratio | 3.26 +32.95% | 2.45 -9.97% | 2.72 +13.44% | 2.40 +34.51% | |
Cash Ratio | 1.55 +48.65% | 1.04 -18.84% | 1.28 +5.77% | 1.21 +7.53% | |
Debt-to-Equity Ratio | 0.13 -9.82% | 0.14 -21.36% | 0.18 +9.42% | 0.17 +11.89% | |
Debt-to-Assets Ratio | 0.09 -12.64% | 0.10 -18.89% | 0.12 +9.36% | 0.11 +12.62% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow